838 related articles for article (PubMed ID: 16020603)
1. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
2. Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodelling in rats.
Xu X; Wan W; Ji L; Lao S; Powers AS; Zhao W; Erikson JM; Zhang JQ
Cardiovasc Res; 2008 Jun; 78(3):523-32. PubMed ID: 18252761
[TBL] [Abstract][Full Text] [Related]
3. Persistent cardiac aldosterone synthesis in angiotensin II type 1A receptor-knockout mice after myocardial infarction.
Katada J; Meguro T; Saito H; Ohashi A; Anzai T; Ogawa S; Yoshikawa T
Circulation; 2005 May; 111(17):2157-64. PubMed ID: 15851599
[TBL] [Abstract][Full Text] [Related]
4. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
6. Borderzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice.
Gilson WD; Epstein FH; Yang Z; Xu Y; Prasad KM; Toufektsian MC; Laubach VE; French BA
J Am Coll Cardiol; 2007 Oct; 50(18):1799-807. PubMed ID: 17964046
[TBL] [Abstract][Full Text] [Related]
7. Relationship between remodeling and function of left ventricle and angiotensin II AT1 receptor expression after myocardial infarction in rats.
Zhang G; Yang Y; Pu S; Shen X; Peng T; Chen H
Chin Med J (Engl); 1999 Jul; 112(7):593-6. PubMed ID: 11601250
[TBL] [Abstract][Full Text] [Related]
8. Transitory reduction in angiotensin AT2 receptor expression levels in postinfarct remodelling in rat myocardium.
Lax CJ; Domenighetti AA; Pavia JM; Di Nicolantonio R; Curl CL; Morris MJ; Delbridge LM
Clin Exp Pharmacol Physiol; 2004 Aug; 31(8):512-7. PubMed ID: 15298543
[TBL] [Abstract][Full Text] [Related]
9. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
[TBL] [Abstract][Full Text] [Related]
10. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin AT2 receptor deficiency after myocardial infarction: its effects on cardiac function and fibrosis depend on the stimulus.
Tschöpe C; Westermann D; Dhayat N; Dhayat S; Altmann C; Steendijk P; Schultheiss HP; Walther T
Cell Biochem Biophys; 2005; 43(1):45-52. PubMed ID: 16043882
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats.
Nomoto T; Nishina T; Miwa S; Tsuneyoshi H; Maruyama I; Nishimura K; Komeda M
Circulation; 2002 Sep; 106(12 Suppl 1):I115-9. PubMed ID: 12354719
[TBL] [Abstract][Full Text] [Related]
14. Effects of ramipril on cardiac gene transcription levels of angiotensin II receptors after myocardial infarction.
Zhu YC; Zhu YZ; Li J; Schäfer H; Schmidt WE; Unger T; Yao T
Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):481-5. PubMed ID: 10678136
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection after angiotensin II type 1 blockade involves angiotensin II type 2 receptor expression and activation of protein kinase C-epsilon in acutely reperfused myocardial infarction in the dog. Effect of UP269-6 and losartan on AT1 and AT2-receptor expression and IP3 receptor and PKCepsilon proteins.
Xu Y; Menon V; Jugdutt BI
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):184-95. PubMed ID: 11967812
[TBL] [Abstract][Full Text] [Related]
16. Effects of amlodipine versus enalapril on left ventricular remodelling after reperfused anterior myocardial canine infarction.
Jugdutt BI
Can J Cardiol; 1997 Oct; 13(10):945-54. PubMed ID: 9374951
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction.
Matsusaka H; Kinugawa S; Ide T; Matsushima S; Shiomi T; Kubota T; Sunagawa K; Tsutsui H
J Cardiovasc Pharmacol; 2006 Sep; 48(3):95-102. PubMed ID: 17031262
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1a receptor is involved in cell infiltration, cytokine production, and neovascularization in infarcted myocardium.
Toko H; Zou Y; Minamino T; Masaya M; Harada M; Nagai T; Sugaya T; Terasaki F; Kitaura Y; Komuro I
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):664-70. PubMed ID: 14962948
[TBL] [Abstract][Full Text] [Related]
20. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
